Faeth Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Faeth Therapeutics, Inc. (FTH) had Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year of $540.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear · last filed 2026-08-04
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $540.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $984.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $428.00K.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $852.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $540.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | $984.00K 10-Q · filed 2026-05-15 |
| 2025-09-30 | $428.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $852.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $1.27M 10-Q · filed 2025-05-06 |
| 2024-09-30 | $476.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $930.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.40M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $457.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $875.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $1.32M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $400.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $801.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.20M 10-Q · filed 2022-05-10 |
| 2021-09-30 | $391.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $680.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $796.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |